Medisca announces new CEO.

Read More >

ORA
library

With over 20 years of rich brand legacy, ORA is renowned in the compounding industry for its impact on pediatric and geriatric medicine. Backed by 150+ stability studies, ORA is the go-to option for compounded oral medications, even making its mark in department stores and FDA-approved finished drugs.

Search over 150 ORA studies

API(s)
BaseStudies & storage at RF*Studies & storage at RT*
Publication Link
AcetazolamideOra-Sweet:Ora Plus / Ora-Sweet SF:Ora Plus60 days at 5°C60 days at 25°C
AllopurinolOra-Sweet:Ora Plus / Ora-Sweet SF:Ora Plus60 days at 5°C 60 days at 25°C
AlprazolamOra-Sweet:Ora Plus / Ora-Sweet SF:Ora Plus60 days at 5°C 60 days at 25°C
AmiodaroneOra-Sweet:Ora Plus / Ora-Sweet SF:Ora Plus91 days at 4°C42 days at 25°C
Amlodipine BesylateOra-Sweet:Ora-Plus / 1% Methylcellulose: Simple Syrup91 days at 4°C56 days at 25°C
AmphetamineOra-Sweet:Ora PlusNA30 days at 25°C
AprepitantOra-Blend111 days at 4°C 111 days at 23°C
AtenololOra-Sweet SF NA90 days
AtenololOra-Sweet / Ora-Plusnot stablenot stable
AzathioprineOra-Sweet:Ora Plus / Ora-Sweet SF:Ora Plus60 days at 5°C 60 days at 25°C
BaclofenOra-Sweet:Ora Plus / Ora-Sweet SF:Ora Plus 60 days 5°C 60 days 25°C
Benazepril HydrochlorideOra-Sweet:Ora-Plus 30 daysNA
BethanecholOra-Sweet:Ora Plus / Ora-Sweet SF:Ora Plus60 days at 5°C60 days at 25°C
CaptoprilOra-Sweet:Ora-Plus14 days at 5°C7 days at 25°C
CaptoprilOra-Sweet SF:Ora-Plus10 days at 5°C5 days at 25°C
CarbamazepineOra-Sweet SF:Ora-PlusNA180 days at 23°C
CelecoxibOra-Blend93 days at 5°C 93 days at 23°C
Chloroquine PhosphateOra-Sweet:Ora Plus / Ora-Sweet SF:Ora Plus60 days at 5°C60 days at 25°C
Ciprofloxacin HydrochlorideOra-Plus:Simple Syrup NF56 days at 3-5°C56 days at 23-25°C
CisaprideOra-Sweet:Ora Plus / Ora-Sweet SF:Ora Plus60 days at 5°C60 days at 25°C

Rows per page

1 - 20

View ORA Brochure

Speak to an expert today

From regulatory compliance to subject matter expertise, our team of pharmacists provides tailored solutions to elevate your compounding practice.
Disclaimer:

*Excludes United States, Israel, and Australia

The Studies Data referenced herein Is used with permission by Padagis US LLC.

*RF = Refrigerated Temperature (2-8C) according to USP <659>

*RT = Room Temperature (20-25C) according to USP <659> </span>

This data is provided for informational purposes only, representing the results of a study of the product stability with various active pharmaceutical ingredients. For further information on packaging, please refer to the actual formula. This document does not serve, and may not be construed, as a representation or guarantee of product performance. In all cases, the practitioner is advised to consult recognized pharmaceutical compendia and other recognized sources for product formulation and other product characteristics, including stability. MEDISCA and its affiliates make no warranties or representations with regards to the functioning or appropriateness of this product in any compounded formulation, the use of which is solely at the discretion and liability of the practitioner. It is the responsibility of the pharmacist or other appropriately state licensed professional to verify the accuracy and validity of the information contained herein, with regards to scheduling, federal and state/provincial laws allowing the use of the formulas, products and final compounds in the country of use.